CompletedNot Applicable

Extended Follow-Up of the ISS T-003 Trial Volunteers (ISS T-003 EF-UP2020)

South Africa179 participantsStarted 2023-01-25

Plain-language summary

A further extension of the follow-up of the volunteers of the ISS T-003 trial is being conducted in order to evaluate the persistence of vaccine immunogenicity as well as of the immunological and virological effects induced by the therapeutic immunization with Tat after about 10 years from vaccination.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * previous participation in the ISS T-003 EF-UP study without withdrawal of consent; * availability to participate in the ensuing extended follow-up study; * signed informed consent. Exclusion Criteria: * The absence of any of the above criteria will exclude the participants from the study.

What they're measuring

Anti-Tat humoral Immune responses

Timeframe: Week 0 and week 24

Trial details

NCT IDNCT05680948

SponsorIstituto Superiore di Sanità

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12-31

View on ClinicalTrials.gov More HIV Infections trials